Amy Shaw

Head of Process Development at Takeda Pharmaceuticals

Speaker

Amy Shaw is the Head of Process and Product Development at Takeda Pharmaceuticals, where she leads CMC strategy for viral vector and cell therapy programs from early development through IND and clinical manufacturing. She oversees process development, technology transfer, and scalable manufacturing for allogeneic cell therapies. With over a decade of experience, she has led multiple IND-enabling programs, with expertise in process characterization, comparability, and lifecycle management. Prior to Takeda, she contributed to the development of Kymriah at Novartis and held roles at Beam and Torque Therapeutics advancing GMP-compliant cell therapy platforms into clinical development.